Revelation Biosciences Warrant
REVBW
11 hedge funds and large institutions have $6.66K invested in Revelation Biosciences Warrant in 2026 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 11 → 11 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
35% less capital invested
Capital invested by funds: $10.2K → $6.66K (-$3.56K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$5 |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$3 |
| 3 |
CS
Clear Street
New York
|
+$2 |
| 4 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
+$1 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PIS
POM Investment Strategies
Raleigh,
North Carolina
|
-$8 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
LA
1
Linden Advisors
New York
| $2.63K | – | – | – |
|
|
PVI
2
Pine Valley Investments
Marlton,
New Jersey
| $1.65K | – | – | – |
|
|
3
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| $896 | +$1 | +100 | +0.1% |
|
|
WAM
4
Wolverine Asset Management
Chicago,
Illinois
| $498 | – | – | – |
|
5
Jane Street
New York
| $388 | – | – | – |
|
|
SIA
6
Soltis Investment Advisors
St. George,
Utah
| $318 | – | – | – |
|
|
7
Citadel Advisors
Miami,
Florida
| $285 | +$3 | +302 | +0.9% |
|
|
8
UBS Group
Zurich,
Switzerland
| $4 | +$5 | +532 | New |
|
|
QWM
9
Quaker Wealth Management
Moorestown,
New Jersey
| $3 | – | – | – |
|
|
PIS
10
POM Investment Strategies
Raleigh,
North Carolina
| – | -$8 | -1,005 | Closed |
|
|
CS
11
Clear Street
New York
| – | +$2 | +200 | +0.1% |
|
REVBW Hedge Fund Activity: Q1 2026 in Review
11 of the 8,127 institutional investors tracked by Wall St. Rank reported a position in Revelation Biosciences Warrant (REVBW) for Q1 2026, worth a combined $6.66K — down 35% from $10.2K a quarter earlier.
Fund positioning in REVBW was balanced in Q1 2026: 1 fund opened new positions, 1 closed out, 3 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $5. The largest seller was POM Investment Strategies, exiting entirely with an estimated $8 sold.
- 11 institutional investors held Revelation Biosciences Warrant (REVBW) as of Q1 2026, unchanged from Q4 2025.
- Funds reported $6.66K of Revelation Biosciences Warrant stock for Q1 2026, down 35% quarter-over-quarter.
- 1 fund opened new Revelation Biosciences Warrant positions in Q1 2026 and 1 closed out, a net change of 0 holders.
- The largest Revelation Biosciences Warrant buyer in Q1 2026 was UBS Group, an estimated $5 added.
- The largest Revelation Biosciences Warrant seller in Q1 2026 was POM Investment Strategies, an estimated $8 sold.
Based on aggregated 13F filings for Q1 2026.